Gray Wealth Management Inc. Has $387,000 Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Gray Wealth Management Inc. lifted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 15.3% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 768 shares of the healthcare conglomerate’s stock after purchasing an additional 102 shares during the quarter. Gray Wealth Management Inc.’s holdings in UnitedHealth Group were worth $387,000 at the end of the most recent quarter.

A number of other hedge funds also recently modified their holdings of the business. Keebeck Wealth Management LLC raised its position in UnitedHealth Group by 11.6% in the 2nd quarter. Keebeck Wealth Management LLC now owns 10,788 shares of the healthcare conglomerate’s stock valued at $5,185,000 after buying an additional 1,122 shares during the last quarter. D.A. Davidson & CO. raised its position in UnitedHealth Group by 24.0% in the 2nd quarter. D.A. Davidson & CO. now owns 42,045 shares of the healthcare conglomerate’s stock valued at $20,209,000 after buying an additional 8,144 shares during the last quarter. Great Diamond Partners LLC raised its position in UnitedHealth Group by 1.7% in the 2nd quarter. Great Diamond Partners LLC now owns 7,033 shares of the healthcare conglomerate’s stock valued at $3,380,000 after buying an additional 118 shares during the last quarter. Private Ocean LLC raised its position in UnitedHealth Group by 37.1% in the 2nd quarter. Private Ocean LLC now owns 1,272 shares of the healthcare conglomerate’s stock valued at $612,000 after buying an additional 344 shares during the last quarter. Finally, Blue Chip Partners LLC raised its position in UnitedHealth Group by 0.5% in the 2nd quarter. Blue Chip Partners LLC now owns 49,995 shares of the healthcare conglomerate’s stock valued at $24,030,000 after buying an additional 228 shares during the last quarter. Institutional investors and hedge funds own 85.69% of the company’s stock.

Insider Activity at UnitedHealth Group

In related news, EVP Erin Mcsweeney sold 4,498 shares of the stock in a transaction that occurred on Monday, October 16th. The stock was sold at an average price of $544.28, for a total transaction of $2,448,171.44. Following the completion of the sale, the executive vice president now directly owns 9,218 shares of the company’s stock, valued at $5,017,173.04. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 4,498 shares of the stock in a transaction on Monday, October 16th. The stock was sold at an average price of $544.28, for a total transaction of $2,448,171.44. Following the completion of the transaction, the executive vice president now directly owns 9,218 shares of the company’s stock, valued at $5,017,173.04. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Stephen J. Hemsley sold 66,081 shares of the stock in a transaction on Tuesday, December 5th. The shares were sold at an average price of $550.39, for a total value of $36,370,321.59. Following the transaction, the director now directly owns 635,528 shares of the company’s stock, valued at $349,788,255.92. The disclosure for this sale can be found here. Over the last three months, insiders sold 192,094 shares of company stock valued at $104,507,072. 0.35% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on UNH. UBS Group upgraded UnitedHealth Group from a “neutral” rating to a “buy” rating and raised their price target for the company from $520.00 to $640.00 in a research note on Monday, October 16th. Stephens reiterated an “overweight” rating and set a $585.00 target price on shares of UnitedHealth Group in a research note on Wednesday, December 13th. Morgan Stanley lowered their price target on UnitedHealth Group from $587.00 to $579.00 and set an “overweight” rating for the company in a report on Monday, October 23rd. Jefferies Financial Group lowered their price target on UnitedHealth Group from $565.00 to $503.00 and set a “hold” rating for the company in a report on Monday, November 20th. Finally, Truist Financial reissued a “buy” rating and set a $610.00 price target on shares of UnitedHealth Group in a report on Thursday, November 30th. One research analyst has rated the stock with a sell rating, one has issued a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $574.89.

View Our Latest Stock Report on UNH

UnitedHealth Group Trading Down 3.3 %

NYSE UNH opened at $521.63 on Friday. The business’s 50-day moving average price is $537.04 and its two-hundred day moving average price is $513.24. UnitedHealth Group Incorporated has a 12 month low of $445.68 and a 12 month high of $554.70. The firm has a market capitalization of $482.47 billion, a PE ratio of 22.64, a price-to-earnings-growth ratio of 1.46 and a beta of 0.56. The company has a current ratio of 0.80, a quick ratio of 0.80 and a debt-to-equity ratio of 0.65.

UnitedHealth Group (NYSE:UNHGet Free Report) last released its quarterly earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 EPS for the quarter, beating analysts’ consensus estimates of $5.98 by $0.18. UnitedHealth Group had a return on equity of 26.58% and a net margin of 6.02%. The firm had revenue of $94.43 billion for the quarter, compared to analyst estimates of $92.13 billion. During the same quarter in the previous year, the company posted $5.34 EPS. The business’s revenue was up 14.1% on a year-over-year basis. On average, analysts expect that UnitedHealth Group Incorporated will post 24.94 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 12th. Investors of record on Monday, December 4th were given a dividend of $1.88 per share. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.44%. The ex-dividend date of this dividend was Friday, December 1st. UnitedHealth Group’s payout ratio is 32.64%.

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Recommended Stories

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.